Galith Abourbeh

771 total citations
20 papers, 644 citations indexed

About

Galith Abourbeh is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Galith Abourbeh has authored 20 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Radiology, Nuclear Medicine and Imaging, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Galith Abourbeh's work include Lung Cancer Treatments and Mutations (10 papers), HER2/EGFR in Cancer Research (9 papers) and Medical Imaging Techniques and Applications (8 papers). Galith Abourbeh is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), HER2/EGFR in Cancer Research (9 papers) and Medical Imaging Techniques and Applications (8 papers). Galith Abourbeh collaborates with scholars based in Israel, United States and Netherlands. Galith Abourbeh's co-authors include Eyal Mishani, Alexander Levitzki, Orit Jacobson, Carolyn J. Anderson, Benoît Thezé, Renaud Maroy, Bertrand Tavitian, Frédéric Dollé, Raphaël Boisgard and Albertine Dubois and has published in prestigious journals such as Journal of Neuroscience, ACS Nano and Scientific Reports.

In The Last Decade

Galith Abourbeh

20 papers receiving 625 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Galith Abourbeh Israel 12 344 275 252 136 69 20 644
Herman Gill United States 17 593 1.7× 357 1.3× 110 0.4× 253 1.9× 83 1.2× 21 860
Kwamena E. Baidoo United States 17 431 1.3× 253 0.9× 107 0.4× 190 1.4× 72 1.0× 30 801
Jeff N. Tinianow United States 11 292 0.8× 156 0.6× 77 0.3× 129 0.9× 40 0.6× 14 492
Sébastien Gouard France 18 450 1.3× 259 0.9× 178 0.7× 159 1.2× 28 0.4× 37 758
Aileen Hoehne United States 15 235 0.7× 305 1.1× 52 0.2× 205 1.5× 36 0.5× 22 763
Alexander Vanderbilt United States 11 262 0.8× 161 0.6× 72 0.3× 117 0.9× 37 0.5× 12 433
Sylvie Froidevaux Switzerland 15 794 2.3× 550 2.0× 110 0.4× 414 3.0× 81 1.2× 38 1.4k
Bernadette Marquez‐Nostra United States 14 440 1.3× 312 1.1× 80 0.3× 125 0.9× 35 0.5× 29 622
D D Bigner United States 10 278 0.8× 228 0.8× 148 0.6× 369 2.7× 17 0.2× 13 940
Sara Kenkare-Mitra United States 4 847 2.5× 1.0k 3.7× 154 0.6× 426 3.1× 77 1.1× 5 1.3k

Countries citing papers authored by Galith Abourbeh

Since Specialization
Citations

This map shows the geographic impact of Galith Abourbeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Galith Abourbeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Galith Abourbeh more than expected).

Fields of papers citing papers by Galith Abourbeh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Galith Abourbeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Galith Abourbeh. The network helps show where Galith Abourbeh may publish in the future.

Co-authorship network of co-authors of Galith Abourbeh

This figure shows the co-authorship network connecting the top 25 collaborators of Galith Abourbeh. A scholar is included among the top collaborators of Galith Abourbeh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Galith Abourbeh. Galith Abourbeh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Orevi, Marina, Simona Ben‐Haim, Galith Abourbeh, et al.. (2022). False Positive Findings of [18F]PSMA-1007 PET/CT in Patients After Radical Prostatectomy with Undetectable Serum PSA Levels. Frontiers in Surgery. 9. 943760–943760. 11 indexed citations
2.
Shamni, Ofer, et al.. (2021). Development and preclinical evaluation of novel fluorinated ammonium salts for PET myocardial perfusion imaging. Scientific Reports. 11(1). 19693–19693. 3 indexed citations
3.
Shamni, Ofer, et al.. (2018). Development of a Fluorinated Analogue of Erlotinib for PET Imaging of EGFR Mutation–Positive NSCLC. Molecular Imaging and Biology. 21(4). 696–704. 9 indexed citations
4.
Hansen, Søren B., Galith Abourbeh, Maqsood Yaqub, et al.. (2017). A multi species evaluation of the radiation dosimetry of [ 11 C]erlotinib, the radiolabeled analog of a clinically utilized tyrosine kinase inhibitor. Nuclear Medicine and Biology. 47. 56–61. 6 indexed citations
5.
Dreifuss, Tamar, Menachem Motiei, Oshra Betzer, et al.. (2017). Glucose-functionalized gold nanoparticles as a metabolically targeted CT contrast agent for distinguishing tumors from non-malignant metabolically active processes. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 10077. 100770I–100770I. 2 indexed citations
6.
Motiei, Menachem, Tamar Dreifuss, Oshra Betzer, et al.. (2016). Differentiating Between Cancer and Inflammation: A Metabolic-Based Method for Functional Computed Tomography Imaging. ACS Nano. 10(3). 3469–3477. 44 indexed citations
7.
Abourbeh, Galith, et al.. (2015). Identifying erlotinib-sensitive non-small cell lung carcinoma tumors in mice using [11C]erlotinib PET. EJNMMI Research. 5(1). 4–4. 26 indexed citations
8.
Abourbeh, Galith, et al.. (2014). PET Molecular Imaging of Angiogenesis with a Multiple Tyrosine Kinase Receptor-Targeted Agent in a Rat Model of Myocardial Infarction. Molecular Imaging and Biology. 17(2). 222–230. 6 indexed citations
9.
Kesner, Adam, Galith Abourbeh, Eyal Mishani, et al.. (2013). Gating, enhanced gating, and beyond: information utilization strategies for motion management, applied to preclinical PET. EJNMMI Research. 3(1). 29–29. 19 indexed citations
10.
Jacobson, Orit, et al.. (2013). Rat Imaging and In Vivo Stability Studies using [11C]-Dimethyl-Diphenyl Ammonium, a Candidate Agent for PET-Myocardial Perfusion Imaging. Nuclear Medicine and Biology. 40(8). 967–973. 6 indexed citations
11.
12.
Abourbeh, Galith, Alexei Shir, Eyal Mishani, et al.. (2012). PolyIC GE11 polyplex inhibits EGFR‐overexpressing tumors. IUBMB Life. 64(4). 324–330. 49 indexed citations
13.
Ilovich, Ohad, Galith Abourbeh, Moshe Bocher, et al.. (2012). Structure–Activity Relationship and Preclinical Evaluation of Carbon-11-Labeled Ammonium Salts as PET–Myocardial Perfusion Imaging Agents. Molecular Imaging and Biology. 14(5). 625–636. 8 indexed citations
14.
Mishani, Eyal, et al.. (2008). Imaging of EGFR and EGFR Tyrosine Kinase Overexpression in Tumors by Nuclear Medicine Modalities. Current Pharmaceutical Design. 14(28). 2983–2998. 58 indexed citations
15.
Abourbeh, Galith, et al.. (2007). The effect of the [F]-PEG group on tracer qualification of [4-(phenylamino)-quinazoline-6-YL]-amide moiety—An EGFR putative irreversible inhibitor. Applied Radiation and Isotopes. 65(10). 1140–1151. 25 indexed citations
16.
17.
Mishani, Eyal & Galith Abourbeh. (2007). Cancer Molecular Imaging: Radionuclide-Based Biomarkers of the Epidermal Growth Factor Receptor (EGFR). Current Topics in Medicinal Chemistry. 7(18). 1755–1772. 34 indexed citations
18.
19.
20.
Abourbeh, Galith, et al.. (2004). Novel iodine-124 labeled EGFR inhibitors as potential PET agents for molecular imaging in cancer. Bioorganic & Medicinal Chemistry. 12(13). 3421–3429. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Herman Gill Breakdown of academic impact, for papers by Kwamena E. Baidoo Breakdown of academic impact, for papers by Jeff N. Tinianow Breakdown of academic impact, for papers by Sébastien Gouard Breakdown of academic impact, for papers by Aileen Hoehne Breakdown of academic impact, for papers by Alexander Vanderbilt Breakdown of academic impact, for papers by Sylvie Froidevaux Breakdown of academic impact, for papers by Bernadette Marquez‐Nostra Breakdown of academic impact, for papers by D D Bigner Breakdown of academic impact, for papers by Sara Kenkare-Mitra
Rankless by CCL
2026